Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q1 2026 Earnings

Feb 17Confirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.24

0.57

1.39

2.2

Details

Expected EPS

2.198

Actual EPS

-0.24

Surprise EPS

-2.44

Surprise Percent

-110.92%

Description

⁨Halozyme Therapeutics⁩ (⁦HALO⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.